Tag Archive for: Blood

lipstick red shades
fundraising

RougeTx launches with $58M to tackle rare bleeding disorder

Dutch biotech RougeTx has launched with a $58 million (€52 million) series A to take its lead drug RTX-001 toward first-in-human testing in hereditary hemorrhagic telangiectasia (HHT). The round was co-led by BioGeneration Ventures, Angelini Ventures and Kurma Partners, with the European Investment Bank (EIB) participating through Angelini’s Aurea co-investment vehicle.

Read more
Bildschirmfoto_2022-04-05_um_09.22.12.png© Bayer Leverkusen
Stroke

Bayer: At last, success with coagulation factor XIa in phase 3 stroke trial

Bayer can report a success in stroke treatment, even though an earlier study with the same compound had been discontinued due to limited benefit. The approach of inhibiting factor XIa represents a first-in-class example from Leverkusen. Whether the data will be sufficient for regulatory approval remains to be seen.

Read more